France and WHO Cement Longstanding Partnership Through €24 Million Funding Package to Advance Global Health Security

GENEVA — In a significant bolstering of international health cooperation, the French government and the World Health Organization (WHO) formalized a substantial financial and strategic commitment on October 17, 2024. During a high-level meeting at the WHO headquarters in Geneva, His Excellency Mr. Jérôme Bonnafont, Permanent Representative of France to the United Nations and other international organizations in Geneva, joined WHO Director-General Dr. Tedros Adhanom Ghebreyesus to sign seven distinct contribution agreements. The finalized package totals €24 million, channeled through the French Ministry of Europe and Foreign Affairs, and is designed to address a diverse spectrum of global health priorities ranging from chronic disease prevention to acute humanitarian emergency response.

This landmark signing represents the latest chapter in the robust bilateral relationship between France and the United Nations health agency. By combining flexible funding with targeted investments, the new agreements seek to operationalize the core principles of the France–WHO Framework Agreement for 2020–2025. This overarching strategic pact provides the essential legal, administrative, and financial architecture required to align French foreign policy objectives in international development with the technical expertise and normative guidance of the WHO.

A Strategic Framework for Sustainable Global Health

The newly signed €24 million package is notable not only for its financial scale but also for its strategic distribution. A cornerstone of the contribution is a €4.5 million allocation directed entirely to the Core Voluntary Contributions Account (CVCA). Unlike strictly earmarked funding, which can restrict an organization’s ability to pivot during unforeseen crises, fully flexible voluntary funds allow the WHO leadership to allocate resources where they are most urgently needed, bridge critical funding gaps, and maintain organizational agility.

The remaining funds within the €24 million package are meticulously allocated to address some of the most complex and pressing health challenges confronting the international community today. These critical areas include the prevention and management of non-communicable diseases (NCDs), the development and implementation of urban health laboratories, and the advancement of the "One Health" approach—an integrated, unifying framework that balances and optimizes the health of people, animals, and ecosystems.

Furthermore, the agreements provide crucial financial backing for the WHO Contingency Fund for Emergencies (CFE), an essential mechanism that allows the organization to release funds within 24 hours of a declared health emergency to mount immediate, life-saving responses. Specific operational contexts slated for support include the acute health emergency response in Gaza, interventions to curb accelerating cholera outbreaks across multiple regions, and specialized mental health support initiatives for populations affected by the ongoing war in Ukraine.

In addition to these global and regional initiatives, the funding ensures the continued operational capacity of the WHO emergencies center in Lyon, France. This specialized hub plays an indispensable role in international epidemic preparedness, logistics, and rapid response training, serving as a vital node in the global health security architecture.

Chronology of the France-WHO Partnership

The October 2024 signing ceremony is the culmination of years of deliberate, institutionalized collaboration between France and the WHO. Tracing the trajectory of this partnership reveals a consistent deepening of diplomatic and financial ties:

• May 2019: Amid growing global recognition of the need for predictable, flexible financing for multilateral health institutions, discussions intensify regarding a formalized strategic partnership between France and the WHO.
• 2020: France and the WHO officially ratify the multi-year Framework Agreement for the period 2020–2025. This document establishes a unified mechanism for cooperation, aligning French official development assistance with the WHO’s General Programme of Work.
• 2021–2022: As the world grapples with the fallout of the COVID-19 pandemic, France increases its engagement in global health governance, championing equitable access to medical countermeasures, vaccines, and resilient health systems. The WHO emergencies center in Lyon receives reinforced backing from Paris to enhance global epidemiological surveillance.
• May 2024: The World Health Assembly formally approves the Fourteenth General Programme of Work (GPW 14) for the period 2025–2028, setting ambitious global health targets. Recognizing the structural funding deficits facing multilateral agencies, France steps forward as a prominent co-host of the WHO’s inaugural Investment Round.
• October 17, 2024: Ambassador Jérôme Bonnafont and Dr. Tedros Adhanom Ghebreyesus meet at WHO headquarters in Geneva to sign the seven contribution agreements totaling €24 million, directly operationalizing the goals of the Framework Agreement and supporting the transition toward GPW 14.

Official Perspectives and Diplomatic Resonance

Speaking at the signing ceremony, Ambassador Jérôme Bonnafont emphasized the philosophical and strategic underpinnings of France’s enduring commitment to the UN health agency. He noted that France views multilateralism not merely as a diplomatic preference, but as an absolute necessity for tackling transnational health threats that respect no national borders.

"France remains deeply committed to supporting the World Health Organization in its efforts to tackle critical global health challenges," Ambassador Bonnafont stated. "These agreements reflect our shared priorities of promoting health equity, responding to emergencies, and strengthening healthcare systems worldwide. In an era marked by converging crises—from geopolitical conflict to climate-sensitive pathogens—the international community must rely on robust, evidence-based multilateral institutions like the WHO."

Dr. Tedros Adhanom Ghebreyesus echoed these sentiments, expressing profound gratitude on behalf of the organization for France’s consistent leadership, financial reliability, and political advocacy.

"We are immensely grateful to the French Government for its steadfast support to WHO, continued partnership, and leadership in global health," Dr. Tedros remarked. "This contribution will enable us to address key health threats, from non-communicable diseases to emergency response, helping to save lives and protect the most vulnerable populations. Flexible funding, in particular, is the lifeblood of our ability to act swiftly and effectively where the suffering is greatest."

Broader Financial Architecture and the WHO Investment Round

France’s latest contribution of €24 million arrives at a pivotal juncture for the WHO and the broader global health financing landscape. For decades, the organization has grappled with a structural mismatch between its assessed contributions (mandatory dues paid by member states, which historically constituted a small fraction of the budget) and voluntary contributions (which are often heavily earmarked for specific diseases or regions by donors). This dynamic has frequently constrained the WHO’s ability to maintain long-term programmatic stability or respond flexibly to emerging health emergencies.

In response, France has consistently positioned itself as a leading advocate for a fully and flexibly financed WHO. Paris has actively supported historic resolutions to incrementally increase assessed contributions, thereby placing the organization on a more predictable and sustainable financial footing. Furthermore, France’s role as a co-host of the WHO’s first-ever Investment Round underscores its commitment to mobilizing high-quality, flexible resources from a diversified donor base.

The Investment Round is designed to secure the financial resources required to implement the Fourteenth General Programme of Work (2025–2028). By championing this innovative financing approach, France is helping to pioneer a model where multilateral health institutions are insulated from donor fatigue and sudden geopolitical shifts, ensuring they can deliver on their core mandate of promoting universal health coverage, preventing disease outbreaks, and responding to humanitarian emergencies.

Implications for Global Health Security

The practical implications of the €24 million funding package are far-reaching, touching upon both chronic health burdens and acute humanitarian crises.

On the chronic disease front, non-communicable diseases—including cardiovascular conditions, cancer, diabetes, and chronic respiratory ailments—account for the vast majority of global deaths, disproportionately impacting low- and middle-income nations. By dedicating resources to NCD management and urban health initiatives, the France-WHO partnership targets the structural determinants of health in rapidly expanding urban environments where the majority of the global population now resides.

Simultaneously, the integration of the "One Health" approach acknowledges the intricate feedback loops linking animal husbandry, agricultural practices, environmental degradation, and human disease emergence. With the majority of emerging infectious diseases originating in animals, funding directed toward One Health initiatives strengthens the upstream prevention of zoonotic spillover events, potentially averting future pandemics before they cross the threshold into human populations.

In acute settings, the reinforcement of the Contingency Fund for Emergencies and dedicated support for operational theaters such as Gaza, Ukraine, and cholera-endemic zones provide immediate humanitarian relief. In Gaza, where the healthcare infrastructure has been severely compromised, sustained WHO intervention is vital for managing trauma care, preventing infectious disease outbreaks, and delivering essential medical supplies. In Ukraine, ongoing support for mental health infrastructure addresses the profound psychological trauma inflicted on populations enduring prolonged conflict. Meanwhile, targeted interventions against cholera outbreaks prevent localized epidemics from spiraling into regional catastrophes.

Finally, the continued empowerment of the WHO emergencies center in Lyon ensures that the international community retains a high-performance logistics and training hub capable of deploying rapid response teams and medical equipment anywhere in the world at a moment’s notice.

Conclusion

The signing ceremony in Geneva on October 17, 2024, serves as a powerful reaffirmation of the strategic alliance between France and the World Health Organization. By combining substantial financial commitments with a steadfast dedication to flexible funding, structural reform, and multilateral cooperation, France and the WHO are actively shaping a more resilient global health architecture. As the international community looks ahead to the implementation of the Fourteenth General Programme of Work, this partnership stands as a model of how strategic, forward-looking investments can safeguard global health security, protect the most vulnerable populations, and advance the fundamental human right to health for all.